The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms

Neuroscience Letters

Volumn 273, Issue 2, 1999, Pages 85-88

  Schreiber, Shaul ^a   Backer, Maria M ^b   Pick, Chaim G ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antidepressants; Antinociception; Dopamine; Hotplate; Noradrenaline; Opioid receptor subtypes; Pain; Serotonin; Venlafaxine

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BETA FUNALTREXAMINE; CLONIDINE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MORPHINE; NALORPHINE; NALOXONAZINE; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE RECEPTOR; PHENTOLAMINE; RECEPTOR SUBTYPE; SEROTONIN RECEPTOR; VENLAFAXINE; YOHIMBINE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HOT PLATE TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032840655     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00627-8     Document Type: Article

References (21)

1. Banks W.A., Kastin A.J., Trentman T.L., Haynes H.S., Johnson B.G., Galina Z.H. Mediation of serotonin-induced analgesia by the 5-HT receptor in the pentobarbital anaesthetized mouse model. Brain Res. Bull. 21:1988;887-891.
2. Botney M., Fields H.L. Amitriptyline potentiates morphine analgesia by direct action on the central nervous system. Ann. Neurol. 13:1983;160-164.
3. Ellingrod V.L., Perry P.J. Venlafaxine: a heterocyclic antidepressant. Am. J. Hosp. Pharm. 51:1994;3000-3046.
4. Gomaa A.A., Mohamed L.H., Ahmed H.N. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. Eur. J. Pharmacol. 170:1989;129-135.
5. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
6. Lloyd G.K., Cronin S., Fletcher A., Mitchell P.J. The profile of venlafaxine, a novel antidepressant agent, in behavioral antidepressant drug models. Clin. Neuropharm. 15:(Suppl. 1; part B):1992;428B.
7. Mendlewicz J. Pharmacologic profile and efficacy of venlafaxine. Int. Clin. Psychopharmacol. 10:(Suppl. 2):1995;5-13.
8. Michael-Titus A., Bousselmame R., Costentin J. Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link. Eur. J. Pharmacol. 187:1990;201-207.
9. Moyer J.A., Andree T.H., Haskins J.T., Husbands G.E.M., Muth E.A. The preclinical pharmacological profile of venlafaxine: a novel antidepressant agent. Clin. Neuropharm. 15:(Suppl. 1; part B):1992;435B.
10. Muth E.A., Haskins J.T., Moyer J.A., Husbands G.E.M., Nielsen S.T., Sigg E.B. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem. Pharmacol. 35:1986;4493-4497.
11. Paul D., Pasternak G.W. Differential blockade by naloxonazine of two μ opiate actions: analgesia and gastrointestinal transit. Eur. J. Pharmacol. 149:1988;403-404.
12. Pick C.G., Paul D., Eison M.S., Pasternak G.W. Potentiation of opioid analgesia by the antidepressant nefazodone. Eur. J. Pharmacol. 211:1992;375-381.
13. Richelson E. Synaptic effects of antidepressants. J. Clin. Psychopharmacol. 16:(Suppl. 2):1996;1S-9S.
14. Sacerdote P., Brini A., Mantegazza P., Panerai E.A. A role for serotonin and β-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol. Biochem. Behav. 26:1987;153-158.
15. Schreiber S., Backer M.M., Pick C.G. The antinociceptive effect of fluvoxamine. Eur. Neuropsychopharmacol. 6:1996;281-284.
16. Schreiber S., Backer M.M., Kaufman J., Rigai T., Pick C.G. Interaction between the tetracyclic antidepressant Mianserin HCl and opioid receptors. Eur. Neuropsychopharmacol. 8:1998;297-302.
17. Schreiber S., Backer M.M., Weizman R., Pick C.G. The antinociceptive effects of fluoxetine. Pain Clinic. 9:1996;349-356.
18. Schreiber S., Getslev V., Weizman A., Pick C.G. The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways. Neurosci. Lett. 253:1998;183-186.
19. Spiegel K., Kalb R., Pasternak G.W. Analgesic activity of tricyclic antidepressant. Ann. Neurol. 13:1983;462-465.
20. Takemori A.E., Ho Y.H., Naeseth J.S., Portoghase P.S. Nor-Binaltrophimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246:(1):1988;255-258.
21. Tura B., Tura S.M. The analgesic effect of tricyclic antidepressants. Brain Res. 518:1990;19-22.